111 related articles for article (PubMed ID: 31787525)
1. Lung recurrence and its therapeutic strategy in patients with pancreatic cancer.
Kurahara H; Maemura K; Mataki Y; Tanoue K; Iino S; Kawasaki Y; Idichi T; Arigami T; Mori S; Shinden Y; Higashi M; Ueno S; Shinchi H; Natsugoe S
Pancreatology; 2020 Jan; 20(1):89-94. PubMed ID: 31787525
[TBL] [Abstract][Full Text] [Related]
2. Resected pancreatic ductal adenocarcinomas with recurrence limited in lung have a significantly better prognosis than those with other recurrence patterns.
Wangjam T; Zhang Z; Zhou XC; Lyer L; Faisal F; Soares KC; Fishman E; Hruban RH; Herman JM; Laheru D; Weiss M; Li M; De Jesus-Acosta A; Wolfgang CL; Zheng L
Oncotarget; 2015 Nov; 6(34):36903-10. PubMed ID: 26372811
[TBL] [Abstract][Full Text] [Related]
3. Primary Recurrence in the Lung is Related to Favorable Prognosis in Patients with Pancreatic Cancer and Postoperative Recurrence.
Zheng B; Ohuchida K; Yan Z; Okumura T; Ohtsuka T; Nakamura M
World J Surg; 2017 Nov; 41(11):2858-2866. PubMed ID: 28634843
[TBL] [Abstract][Full Text] [Related]
4. Pancreatic adenocarcinoma: insights into patterns of recurrence and disease behavior.
Sahin IH; Elias H; Chou JF; Capanu M; O'Reilly EM
BMC Cancer; 2018 Jul; 18(1):769. PubMed ID: 30055578
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Value of Metabolic Tumor Volume and Total Lesion Glycolysis on Preoperative ¹⁸F-FDG PET/CT in Patients with Pancreatic Cancer.
Lee JW; Kang CM; Choi HJ; Lee WJ; Song SY; Lee JH; Lee JD
J Nucl Med; 2014 Jun; 55(6):898-904. PubMed ID: 24711649
[TBL] [Abstract][Full Text] [Related]
6. Characteristics of Lung Metastasis as an Initial Recurrence Pattern After Curative Resection of Pancreatic Cancer.
Morimoto D; Yamada S; Sonohara F; Takami H; Hayashi M; Kanda M; Tanaka C; Kobayashi D; Nakayama G; Koike M; Fujiwara M; Fujii T; Kodera Y
Pancreas; 2020; 49(5):699-705. PubMed ID: 32433409
[TBL] [Abstract][Full Text] [Related]
7. Surgical Resection for Pulmonary Metastasis from Pancreatic and Biliary Tract Cancer.
Tagawa T; Ito K; Fukuzawa K; Okamoto T; Yoshimura A; Kawasaki T; Masuda T; Iwaki K; Terashi T; Okamoto M; Shiromizu A; Motohiro A; Maehara Y
Anticancer Res; 2017 Mar; 37(3):1413-1416. PubMed ID: 28314312
[TBL] [Abstract][Full Text] [Related]
8. Improved prognostic value of standardized uptake value corrected for blood glucose level in pancreatic cancer using F-18 FDG PET.
Lee SM; Kim TS; Lee JW; Kim SK; Park SJ; Han SS
Clin Nucl Med; 2011 May; 36(5):331-6. PubMed ID: 21467846
[TBL] [Abstract][Full Text] [Related]
9. Survival Impact of Pulmonary Metastasis as Recurrence of Pancreatic Ductal Adenocarcinoma.
Yamashita K; Miyamoto A; Hama N; Asaoka T; Maeda S; Omiya H; Takami K; Doki Y; Mori M; Nakamori S
Dig Surg; 2015; 32(6):464-71. PubMed ID: 26517228
[TBL] [Abstract][Full Text] [Related]
10. The indolent nature of pulmonary metastases from ductal adenocarcinoma of the pancreas.
Downs-Canner S; Zenati M; Boone BA; Varley PR; Steve J; Hogg ME; Zureikat A; Zeh HJ; Lee KK
J Surg Oncol; 2015 Jul; 112(1):80-5. PubMed ID: 26153355
[TBL] [Abstract][Full Text] [Related]
11. Preoperative FDG-PET predicts early recurrence and a poor prognosis after resection of pancreatic adenocarcinoma.
Yamamoto T; Sugiura T; Mizuno T; Okamura Y; Aramaki T; Endo M; Uesaka K
Ann Surg Oncol; 2015 Feb; 22(2):677-84. PubMed ID: 25190125
[TBL] [Abstract][Full Text] [Related]
12. Oligometastatic pulmonary metastasis in pancreatic cancer patients: Safety and outcome of resection.
Ilmer M; Schiergens TS; Renz BW; Schneider C; Sargut M; Waligora R; Weniger M; Hartwig W; Ceyhan GO; Friess H; Werner J; D'Haese JG
Surg Oncol; 2019 Dec; 31():16-21. PubMed ID: 31473583
[TBL] [Abstract][Full Text] [Related]
13. The Time to and Type of Pancreatic Cancer Recurrence after Surgical Resection: Is Prediction Possible?
Kovač JD; Mayer P; Hackert T; Klauss M
Acad Radiol; 2019 Jun; 26(6):775-781. PubMed ID: 30254003
[TBL] [Abstract][Full Text] [Related]
14. Clinical role of fludeoxyglucose (18F) positron emission tomography/computed tomography (
Matsumoto T; Okabe H; Yamashita YI; Yusa T; Itoyama R; Nakao Y; Yamao T; Umzaki N; Tsukamoto M; Kitano Y; Miyata T; Arima K; Nitta H; Hayashi H; Imai K; Chikamoto A; Baba H
Surg Today; 2019 Jan; 49(1):21-26. PubMed ID: 30128759
[TBL] [Abstract][Full Text] [Related]
15. Surgery for synchronous and metachronous single-organ metastasis of pancreatic cancer: a SEER database analysis and systematic literature review.
Liu Q; Zhang R; Michalski CW; Liu B; Liao Q; Kleeff J
Sci Rep; 2020 Mar; 10(1):4444. PubMed ID: 32157155
[TBL] [Abstract][Full Text] [Related]
16. Impact of preoperative 18F-FDG PET/CT on survival of resected mono-metastatic non-small cell lung cancer.
Tönnies S; Tönnies M; Kollmeier J; Bauer TT; Förster GJ; Kaiser D; Wernecke KD; Pfannschmidt J
Lung Cancer; 2016 Mar; 93():28-34. PubMed ID: 26898611
[TBL] [Abstract][Full Text] [Related]
17. Prognostic evaluations of small size lung cancers by 18F-FDG PET/CT and thin-section CT.
Kishimoto M; Iwano S; Ito S; Kato K; Ito R; Naganawa S
Lung Cancer; 2014 Nov; 86(2):180-4. PubMed ID: 25263854
[TBL] [Abstract][Full Text] [Related]
18. Isolated local recurrence or solitary solid organ metastasis after esophagectomy for cancer is not the end of the road.
Depypere L; Lerut T; Moons J; Coosemans W; Decker G; Van Veer H; De Leyn P; Nafteux P
Dis Esophagus; 2017 Jan; 30(1):1-8. PubMed ID: 27704661
[TBL] [Abstract][Full Text] [Related]
19. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
20. Management of isolated recurrence after surgery for pancreatic adenocarcinoma.
Kim YI; Song KB; Lee YJ; Park KM; Hwang DW; Lee JH; Shin SH; Kwon JW; Ro JS; Kim SC
Br J Surg; 2019 Jun; 106(7):898-909. PubMed ID: 31162655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]